Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Case-CrossovEr Study deSign to Inform Tailored Interventions to Prevent Disease

NCT04743323 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.

NCT NCT04743323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04743323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Case-CrossovEr Study deSign to Inform Tailored Interventions to Prevent Disease
Lead sponsor
Cedars-Sinai Medical Center
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2020
Completion date
June 1, 2024
Enrollment
160 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol drinking, health behavior, pancreatitis, acute